Loading
Yanuki
KEYWORD TOPIC
Calidi Biotherapeutics' Engineered Virus Platform Targets Cancer | Calidi Biotherapeutics' Engineered Virus Platform Targets Cancer

Health / Biotech

Calidi Biotherapeutics' Engineered Virus Platform Targets Cancer

Calidi Biotherapeutics Inc. (NYSE American: CLDI) is pioneering a precision genetic medicine platform for cancer treatment. Their innovative approach uses engineered viruses to deliver genetic medicines directly to both primary tumors and m...

Revolutionary Cancer Treatment: How Engineered Viruses Could Transform Genetic Medicine Delivery
Calidi Biotherapeutics' Engineered Virus Platform Targets Cancer Image via Stock Titan
TOPIC cldi stock